(Q38080371)

28 August 2017

title

Regulation of lymphatic vascular morphogenesis: Implications for pathological (tumor) lymphangiogenesis (English)

1 reference

28 August 2017

1 reference

1 reference

Ines Martinez-Corral

1

1 reference

ORCID Public Data File 2021

author name string

Taija Makinen

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

6 February 2013

1 reference

Experimental Cell Research

28 August 2017

published in

1 reference

28 August 2017

volume

319

1 reference

28 August 2017

issue

11

1 reference

28 August 2017

page(s)

1618-1625

1 reference

The lymphatic vasculature in disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Functionally specialized junctions between endothelial cells of lymphatic vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lymphatic vascular morphogenesis in development, physiology, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Live imaging of lymphatic development in the zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Sox18 induces development of the lymphatic vasculature in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Dual origin of avian lymphatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

A genetic Xenopus laevis tadpole model to study lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Platelets: covert regulators of lymphatic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Hereditary lymphedema: evidence for linkage and genetic heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Angiogenesis: a team effort coordinated by notch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Flow control in our vessels: vascular valves make sure there is no way back

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Emilin1 deficiency causes structural and functional defects of lymphatic vasculature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lymphatic metastasis in the absence of functional intratumor lymphatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Interaction of tumor cells and lymphatic vessels in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lymphangiogenesis and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Myeloid cells and lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic Metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Blocking neuropilin-2 function inhibits tumor cell metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

A model for gene therapy of human hereditary lymphedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Lymphatic dysfunction, not aplasia, underlies Milroy disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.01.016

10.1016/J.YEXCR.2013.01.016

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference